PS
CNMD icon

Principal Securities’s CONMED CNMD Stock Holding History

Principal Securities’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-593
Closed -$27.9K – 1743
2025
Q3 		$27.9K Buy
593
+110
+23% +$5.7K ﹤0.01% 2244
2025
Q2 		$25.2K Sell
483
-116
-19% -$6.37K ﹤0.01% 2206
2025
Q1 		$41K Hold
599
– – ﹤0.01% 1839
2024
Q4 		$41K Sell
599
-2
-0.3% -$139 ﹤0.01% 1836
2024
Q3 		$43.2K Buy
601
+10
+2% +$706 ﹤0.01% 1758
2024
Q2 		$41K Buy
591
+170
+40% +$12.4K ﹤0.01% 1711
2024
Q1 		$33.7K Sell
421
-1
-0.2% -$89 ﹤0.01% 1740
2023
Q4 		$46.2K Buy
+422
New +$43.6K ﹤0.01% 1524

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Principal Securities's CNMD Position: Q4 2025 in Review

Principal Securities sold out of CONMED (CNMD) in Q4 2025, closing a stake of 593 shares — an estimated $27.9K sold.

Principal Securities first reported a position in CNMD in Q4 2023 and held it in 8 quarters. The position peaked at $46.2K in Q4 2023. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Principal Securities reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 593 CONMED shares in Q4 2025, an estimated $27.9K.
  • Principal Securities first reported a position in CONMED in Q4 2023 and held it in 8 quarters.
  • Principal Securities's CONMED position peaked at $46.2K in Q4 2023.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.